85 related articles for article (PubMed ID: 10632639)
41. Medical therapies for ulcerative colitis and Crohn's disease.
Baert FJ; Rutgeerts PJ
Curr Gastroenterol Rep; 2000 Dec; 2(6):446-50. PubMed ID: 11079045
[TBL] [Abstract][Full Text] [Related]
42. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
Clemett D; Markham A
Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
[TBL] [Abstract][Full Text] [Related]
43. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
Frandsen NE; Saugmann S; Marcussen N
Nephron; 2002 Sep; 92(1):200-2. PubMed ID: 12187103
[TBL] [Abstract][Full Text] [Related]
44. Mesalazine-associated interstitial nephritis.
World MJ; Stevens PE; Ashton MA; Rainford DJ
Nephrol Dial Transplant; 1996 Apr; 11(4):614-21. PubMed ID: 8671848
[TBL] [Abstract][Full Text] [Related]
45. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Ransford RA; Langman MJ
Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
[TBL] [Abstract][Full Text] [Related]
46. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
Corrigan G; Stevens PE
Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
[TBL] [Abstract][Full Text] [Related]
47. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
[No Abstract] [Full Text] [Related]
48. 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.
Moss JG; Parry CM; Holt RCL; McWilliam SJ
Eur J Med Res; 2022 Apr; 27(1):61. PubMed ID: 35488310
[TBL] [Abstract][Full Text] [Related]
49. The Association of Mesalamine With Kidney Disease.
Adiga A; Goldfarb DS
Adv Chronic Kidney Dis; 2020 Jan; 27(1):72-76. PubMed ID: 32147005
[TBL] [Abstract][Full Text] [Related]
50. [Interstitial nephritis induced by mesalazine].
Ohya M; Otani H; Kimura K; Kodama N; Minami Y; Liang XM; Maeshima E; Yamada Y; Mune M; Yukawa S
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):414-9. PubMed ID: 12073628
[TBL] [Abstract][Full Text] [Related]
51. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
Gisbert JP; González-Lama Y; Maté J
Inflamm Bowel Dis; 2007 May; 13(5):629-38. PubMed ID: 17243140
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
